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Abstract— According to the World Health Organization [1] , 
15 million people suffer stroke worldwide each year; of these, 5 
million die and 5 million are permanently disabled. Stroke is 
therefore a major cause of mortality world-wide. The majority 
of strokes are caused by a blood clot that occludes an artery in 
the brain, and although thrombolytic agents such as Alteplase 
are used to dissolve clots that arise in the arteries of the brain, 
there are limitations on the use of these thrombolytic agents. 
However over the past decade, other methods of treatment 
have been developed which include Thrombectomy Devices e.g. 
the ‘GP’ Thrombus Aspiration Device (‘GP’ TAD).  Such 
devices may be used as an alternative to thrombolytics or in 
conjunction with them to extract blood clots in arteries such as 
the middle cerebral artery of the midbrain brain, and the 
posterior inferior cerebellar artery (PICA) of the posterior 
aspect of the brain. In this paper, we mathematically model the 
removal of blood clots using the ‘GP’ TAD from selected 
arteries of the brain where blood clots may arise taking into 
account factors such as the resistances, compliances and 
inertances effects. Such mathematical modelling may have 
potential uses in predicting the pressures necessary to extract 
blood clots of given lengths, and masses from arteries in the 
Circle of Willis - posterior circulation of the brain. 
 
Keywords- Biomedical engineering, Thrombectomy Device, 
Circle of Willis, Simulation . 
I.  INTRODUCTION 
According to research conducted by the World Health 
Organization [1], Cardiovascular diseases (CVDs) are the 
number one cause of death globally, more than from any 
other cause. It is estimated that more than 17 million people 
died from this cause in 2004, representing an important 
percentage of all global deaths (29%); an estimated 5.7 
million were due to stroke. Strokes are usually severe events 
and are mainly caused by a blockage that prevents blood 
from flowing to the brain. The most typical reason for this 
blockage is a build-up of fatty deposits on the inner walls of 
the blood vessels that supply the brain. Strokes can also be 
caused by bleeding from a blood vessel in the brain or from 
blood clots. 
The Circle of Willis (fig. 1) supplies blood to the brain. It 
is divided into an anterior aspect of the Circle of Willis and a 
posterior aspect. The posterior aspect supplies the posterior 
parts of the brain including the cerebellum, and occipital 
areas. It is not uncommon for strokes that affect these parts 
of the brain to produce symptoms such as lack of 
coordination, visual disturbances and balance problems. The 
vertebral arteries join to form the basilar artery from which 
joins the Circle of Willis at the posterior aspect of the brain. 
Smaller arteries branch off these arteries to supply the 
different aspects of the hind brain. 
 
 
Figure 1.  Schematic representation of the Circle of Willis. [2] 
Recently thrombolysis has been used to dissolve clots in 
the posterior (as well as the anterior) circulation of the brain. 
However as with the use of thrombolytics in the anterior part 
of the brain, the same constraints apply to its use. Due to the 
risk of hemorrhage it is contraindicated in patients who have 
undergone recent surgery. Therefore it is useful to have more 
than one treatment method available and in the last decade 
the use of mechanical clot retrieval devices has increased.  
During the last decade Thrombectomy Devices have 
become more widely used and have been developed as an 
alternative and more mechanical means for clot removal. The 
need to study new Thrombectomy devices like the one 
described here means that a computer pre-modelling may be 
helpful in the optimization and fine-tuning of such devices 
prior to clinical trials. 
In the case of this study, the device ‘GP’ TAD has been 
designed to remove blood clots without the need to make 
contact with the clot itself, which potentially reduces the risk 
2011 UKSim 13th International Conference on Modelling and Simulation
978-0-7695-4376-5/11 $26.00 © 2011 IEEE
DOI 10.1109/UKSIM.2011.19
48
of problems such as downstream embolisation. The 
extraction of the obstructing element (i.e. the blood clot) by 
the device is done by means of vacuum suction provided by 
the action of a pump. To do this, an increasing pressure is 
applied over time until a value is attained at which the clot is 
captured. The force required to separate the clot from the 
arterial wall is analysed by modelling a compliance-
resistance system to represent the interaction between both 
parts. A viscous damper will be used that allows us to 
consider the change from static to dynamic friction in its 
relative movement. To implement this we define different 
sections of the mechanism studied in the paper. Blood is 
deemed to be an incompressible fluid, while the tube 
between the pump and the ‘GP’ device is deemed to be non- 
elastic. The loss load will be due mainly to the existent flow, 
which by means of previous studies has been shown to be 
laminar. 
Our model is applied to the use of the ‘GP’ TAD to the 
posterior arteries of the brain (PICA, BA and VA), to 
investigate the potential use of such a device and to 
investigate the use of such modeling as a predictor of design 
performance. The main objective of the development of this 
simulation model is to analyze the minimum pressure 
required to perform clot extraction using one fixed adhesion 
force between the clot and the artery wall. It is important that 
both the suction pressure applied and the time required to 
complete the clot extraction are reasonable for use in clinical 
situations, and are consistent with any experimentally 
obtained data. The presented study has been applied for a 
range of lengths and occlusions of blood clot. 
II. GP’ TAD DEVICE STRUCTURE 
The ‘GP’ TAD device (fig. 2) [3] action involves using a 
vacuum pump that provides the necessary suction pressure 
for the operation, joined to a very long catheter ( 1 m). The 
‘GP’ device is located at the end of this catheter. The internal 
surface of the ‘GP’ device has been mathematically designed 
to optimize the distribution of forces. It is also associated 
with low forces at the periphery of the device which may 
therefore reduce the risk of arterial collapse during aspiration 
of the clot [4, 5]. 
The proposed procedure for using this device is to 
introduce it into an artery (via the arterial catheter) in close 
proximity to the occluding blood clot, and to position it at a 
distance of approximately 3 mm from the clot. Then the 
suction pressure is slowly increased until the clot cross the 3 
mm that separates it from the ‘GP’ device and clot capture 
therefore occurs; at his time, the device and the clot would be 
removed from the body easily.  
The device is currently being developed as a potential 
thrombus aspiration device through a series of in vitro 
studies. This device has the potential to be used in relatively 
small arteries. It has no moving parts and therefore should 
reduce the risk of breakage in a vessel. Since it does not 
touch the clot itself it also has the potential to reduce the risk 
of clot disruption (downstream embolisation).  
 
 
Figure 2.  Schematic view of the ‘GP’ Thrombus Aspiration Device. 
The ‘GP’ TAD has been modelled in previous studies 
using different simulation software packages [6], and 
different existing techniques have been considered for the 
modelling and simulation [7]. Some methods which have 
been considered previously for their applicability are the 
Boltzmann flow simulation technique, and finite elements 
modelling and its implementation in Matlab © software, with 
2D or 3D models; or by means of Laplace transformations 
using Dynamic Motion Solver © software. 
The objective of this study is to obtain the optimal 
mathematical model for use in demonstrating the potential 
performance of the ‘GP’ TAD device under different 
conditions of blood flow and size of blood clot, in a given 
vessel. 
III. MATHEMATICAL MODELLING  
This section gives a brief description of the device under 
study, as well as the parts comprising it. We describe the 
model used for the simulation, the phenomena considered, 
and the values of the parameters used are described. 
The vacuum pump creates the necessary suction pressure 
to carry out the extraction, and is positioned at the other end 
of the catheter that does not contain the ‘GP’ TAD. 
If we analyze the schematic view (fig. 2), we can view 
the catheter, ‘GP’ device and artery as a pipe of different 
parameters. It is necessary to analyze the lost of pressure due 
to the mass of fluid, the compressibility that the blood and 
artery are subjected to, and finally the resistances that appear 
when fluid and blood clot flow into the pipe [8]. 
In the model, the suction pump can be represented by a 
variable pressure ‘P’ whose value will increase from zero to 
a non-determined value (0 - [-2,-100] kPa) suitable for 
carrying out the operation of clot removal. The value of ‘P’ 
will be obtained from the optimization of the developed 
model. The time taken to reach the maximum value of 
pressure has been obtained from experiment and is about 3 
sec., after which time the pressure provided by the pump 
remains constant. 
To generate the correct model, it is necessary firstly to 
analyze the flow variation taking into account the pressure 
lost that appears in the different parts of the system. 
 When a fluid goes into a pipe from point 1 to point 2, it 
is necessary to overcome the inertance of the fluid. If we 
consider that the fluid is not compressible and the pipe as a 
non elastic element with no deformations, we can assume 
that the flow ‘Q’ is constant across the pipe. In addition, the 
‘momentum’ associated with the inertances can be defined as 
the product of the inertance value and the flow. 
 QImp ·          (1) 
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On the other hand, if we consider that a force is equal to 
the fluid mass multiplied by the acceleration of it, which is 
corresponding with the derived velocity of the fluid (Q/A), 
we have that: 
   



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, where ‘P1’ and ‘P2’ are the existent pressure in two points 
of a pipe, ‘’ is the density of the fluid, ‘A’ the section pipe, 
and ‘L’ the length between the two points 1 and 2. 
Simplifying previous equation, we can conclude that: 
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On the other hand, the ‘momentum’ associated to the 
inertances (eq. 1) can be defined additionally as: 
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
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By replacing eq. (3) into eq. (4), we can write that: 
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Finally, if we compare eqs. (1) and (5) we can conclude 
that the inertance corresponding with a fluid flowing into a 
pipe can be written as: 
 
 ALI /·          (6) 
 
Once defined the effect corresponding with the inertance 
effect of a fluid flowing into a pipe can be evaluated, and we 
can define the different equations that are associated with the 
first section of the schematic view as shown in the following 
figure. 
 
Figure 3.  Schematic view of the ‘GP’ Thrombus Aspiration Device. 
If we take into account the equation (3), the derived flow 
of the fluid that goes into the catheter can be defined as the 
pressure difference between beginning and end points 
divided by the inertance of the fluid (blood). The pressure 
lost is not only the difference of pressure between point A 
(depressure pump) and B, but the effect of the linear load 
loss ‘R’ due to the friction between the liquid particles and 
the catheter walls, taking the next expression: 
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To simplify, only linear load losses have been taken into 
account. If we suppose that the catheter is composed of 
successive horizontal pipes of constant cross section in each 
section, the load loss is reduced to a pressure loss as the fluid 
advances along the catheter, the loss being progressive and 
proportional to the length of the catheter. If we assume that 
the blood flow is laminar due to the Reynolds number being 
approximately 1.000 (Re<2.200), the equation that governs 
the behaviour in the catheter can be determined by the 
following expression: 
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, where ‘’ is the viscosity of the fluid, and ‘D’ the diameter 
of the catheter. Some studies show that in diseased arteries 
the viscosity of the blood varies, increasing its value but for 
this first approximation we used a normal value of 0.0035 
Pa·s. 
In the same way, the resulting flow of blood that goes 
into the ‘GP’ device can be defined as the pressure difference 
between beginning and end points divided by the inertance 
of the content blood: 
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In addition, since the artery is located near the end of the 
‘GP’ TAD, it is necessary to consider the transition between 
both elements as a secondary load loss caused by the 
deflecting nozzle due to the difference in diameter of the 
‘GP’ device and the artery respectively. The latter can give 
rise to subsequent variations in flow. These load losses can 
be represented as a resistance and can be calculated as a 
function of the mean value (Dm) between the diameter of the 
catheter and the diameter of the artery, and the load loss 
coefficient () which is a dimensionless parameter that 
quantifies the loss produced and depends on the geometry of 
the deflecting nozzle, with the following expression: 
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, where ‘Qartery’ is the flow which circulates in the section 
between the end of the ’GP’ device and the artery. 
Taking this into account, (with respect to the tip of the 
‘GP’ and the part of artery that goes from this point to the 
blood clot), we can define the derived equation including the 
effect of the linear load loss due to the friction between the 
liquid particles and the artery walls, and the secondary losses 
caused by the deflecting nozzle: 
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Once these  equations have been defined in the model, it 
is necessary to change from the hydraulic to the mechanical 
domain before considering the clot element, to be able to 
evaluate the clot extraction taking into account the physical 
friction between the clot and the artery.  
To formulate the corresponding equations from the 
different described phenomena, it is necessary to assume that 
the flow after and before resistances and inertances are the 
same. 
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IV. CLOT MATHEMATICAL MODELLING 
Accurately defining the clot model in order to model it is 
the most complex part of the model. In the case of a 100% 
blood clot occlusion, including the existence of plaque or 
not, we can in both cases approximate the clot as a 
cylindrically-shaped element of [0.5-5] cm long, and of a 
mass that falls between [0.5-0.1] gram. This element has 
usually formed in another location, usually in a vascular 
artery, and has become dislodged remaining trapped in 
smaller diameter arteries, such as the Circle of Willis arteries 
considered in this work. Therefore, due to this difference in 
diameter, the clot becomes attached to the wall by a force of 
adhesion that needs to be overcome in order to begin 
movement of the clot for its removal. In addition, the relative 
movement between the clot and the artery presents static and 
dynamic friction, which needs to be taken into account. If a 
correct approximation to reality is to be achieved all these 
phenomena, as well as the circumstances restricting clot 
movement, need to be considered. 
As already stated, the phenomenon preventing clot 
movement is the difference in diameter between the clot and 
the artery where it is located. Experimental data 
demonstrated that low times of residence of the clot in the 
artery, the value of the adhesion force is 0.01N, which value 
will be considered. 
In order to decide when to begin the movement of the 
obstructive element, firstly we need to insert a spring ‘Kclot’ 
into the model to measure the force supported by the 
beginning of the clot and its deformation. 
 
Figure 4.  Force supported by the beginning of the clot. 
To know when the force will be reached in this 
equivalent spring and, therefore, when the clot movement 
will begin, it is essential to calculate the displacement of the 
spring when it is subjected to 0.01 N through a typical spring 
equation. Therefore, only when the spring undergoes this 
displacement should the clot be allowed to move; to the 
contrary it would be prevented. 
Secondly, the friction between the clot and the arterial 
wall creates another resistance factor. The value of this 
parameter must be variable depending on whether the clot 
has not begun its movement (static friction) or if it is already 
moving (dynamic friction), so that when the clot begins to 
move the friction value will drop considerably. This value is 
obtained starting from the Stokes equation and can be given 
a value of 2.5·10-6 N·s/m for the static friction and one order 
of magnitude lower than for the dynamic friction. The 
transition between both values marks the beginning or end of 
the clot movement by means of the displacement of the 
spring previously defined ‘Kclot’. So, when the displacement 
undergone by this spring is less than that calculated, static 
friction will predominate; to the contrary, if it is greater, then 
the friction will be dynamic. 
Additionally, to ensure that the clot remains at rest while 
the force existing at its beginning is less than the adhesion 
force, a spring-damper system joined to a wall must be used 
(Kwall and Rwall). In this system, while the clot doesn´t receive 
the force of minimum suction (that would cause it to move), 
it has a zero speed. However, when it begins to move, the 
spring-damper system must be cancelled allowing its 
extraction.  
 
a).         b).             c). 
Figure 5.  Detailed view of contact blood clot – artery/plaque wall. 
a).Fsuction=0.0 N, b). Fsuction<0.01 N, c). Fsuction>0.01 N 
Therefore, while the force representing the deformation 
of the clot is lower than the adhesion force, it will remain 
attached to the wall, thereby preventing any movement. 
However, if the force exceeds the value of the adhesion force 
the spring-damper system will be eliminated with the clot 
becoming free and moving in accordance with the suction 
pressure acting on it from the system, allowing it to be 
removed. The elimination of the spring-damper system will 
be performed from the displacement of the spring 
representing the clot deformation, as was seen in the 
condition imposed on the static/dynamic friction. After 
different experiments, the optimum values of this spring-
dumper are of 1010 N/m and 109 N·s/m respectively. 
In addition to the spring and the resistance inserted, the 
model must have an inertance element that represents the 
mass of the clot ‘Mclot’. 
After previous arguments, we can define the 
decceleration of the clot according to pressures and the 
values of the spring and dampers as eluded to above in the 
modelling. We take into account the necessity to change 
from the hydraulic to the mechanical domain. This is 
necessary to introduce the area of the clot multiplying the 
pressure before the clot. Finally, the equation can be 
generated as the sum of the force associated with the 
pressure existing near the clot ‘PD’ (fig. 3), and the forces 
associated with the resistances and compliances, taking the 
necessary signs into account. 
 
 
clot
KwallclotclotwallDclotclot
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dt
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       (12) 
V. COMPRESSIBILITY PHENOMENA 
In a pipe, the fluid acts as a compliance producing a 
decrease in volume when the pressure required for 
compression is increased, and it is necessary to take into 
account the blood compressibility. In our case, we can define 
this behavior associated with the blood as dependent on the 
Bulk's blood coefficient and section of the artery. If we 
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assume a circular geometry, it can be defined as a 
capacitance of ‘Kblood’ value: 
 LDBK ablood 
24 /        (13) 
In addition, it is necessary to take into account the 
compressibility of the pipe material and not only the fluid. 
Although we can assume that catheter and ‘GP’ device are 
incompressible due to the high rigidity, it is necessary to 
insert the compressibility of the length of artery that appears 
between the ‘GP’ device and the clot, in accordance with its 
Young‘s modulus (E): 
 
00 2 rV
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·
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where ‘V0’ is the artery initial volume and ‘r0’ is the artery 
initial radius. 
From consideration of both compressibility phenomena, 
in addition to the system composed with equations (7), (9), 
(11) and (12) it is necessary to introduce other derived 
equations to obtain the different flows from the volumes and 
pressures associated with all these various entities. 
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, where ‘Keq_artery’ is the equivalent compliance due to the 
combination of three compressibilities (fluid artery, material 
of artery and deformation of the clot due to the suction 
force). We therefore apply the necessary domain changes by 
using the clot area (Aclot). 
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Finally, we add in the relationship for the displacement 
of the spring system joined to the wall to ensure that the clot 
remains at rest, such that the force existing at the beginning 
of the analysis is less than the adhesion force and can be 
written in the form: 
 
clot
K V
dt
dX
wall           (19) 
 
With this system of equations, the mathematical model is 
complete and we can begin to determine the necessary times 
associated with the different pressures and values of  
parameters. 
VI. RESULTS 
To obtain the simulation of the developed equations, 
DASSL algorithm will allows obtaining the evolution of the 
characteristic parameters of the model as well as letting them 
be compared. 
The aim of this simulation is to compare the extraction of 
a clot in the VA, BA and PICA arteries considering different 
clot lengths and 70% occlusion. The use of the different 
arteries will affect directly to the used diameters into the 
model and the ‘GP’ and catheter sizes in the next way: 
 
- VA:    Dartery = 5,50 mm  DGP = Dcatheter = 5,0 mm    
- BA:    Dartery = 3,17 mm  DGP = Dcatheter = 3,0 mm    
- PICA:    Dartery = 2,50 mm  DGP = Dcatheter = 2,0 mm    
 
In the previously defined values, the standard elements 
(‘GP’ and catheter) would have normalized values, being 
necessary to choose the nearest diameter value to be inserted 
into the artery. The existence of different clot lengths will 
affect the mass of the clot being removed, and increase the 
time taken for clot removal as the value of the clot length 
increases Finally, an arterial occlusion of 70% will modify 
the area in which the suction force acts, considering that the 
clot reduces the cross-sectional area of the artery.  
The following figures show the time taken to create the 
necessary suction force to move the clot across the 3 mm gap 
between the clot and ‘GP’ device, for different pump suction 
pressures, diameters and clot lengths. 
 
 
 
 
Figure 6.  Pressure vs time required to clot removal. 
Clot length = 0.5 cm 
Clot length = 1.5 cm 
Clot length = 5.0 cm 
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We observe that there is a difference on applying vacuum 
suction in each artery and for different clot lengths. The time 
taken to remove the blood clot in each instance is also 
different for each case. There are clearly differences in the 
times taken to remove the blood clot of various different 
lengths. While for a pressure of -30Kpa the required time is 
below 5 seconds in all cases, the use of smaller suction 
pressures causes the range of times for clot removal to 
increase to 1 minute in some cases, e.g. with -2kPa pressure. 
In some instances, the previous -2kPa pressure sometimes 
increases the required time to more than 10 minutes –these 
cases correspond with the smaller arteries e.g. the PICA. It 
should be noted that the pressure losses are inversely related 
to the artery cross-section. It is possible to speculate that a 
minimum required suction pump pressure must be around -
4kPa or -6kPa, and that the corresponding clot removal times 
would then take less than ¾ or ½ minute. Higher clot 
removal times result when the clot lengths are greater e.g. 
with a 5 cm clot length in the PICA artery, (which is one of 
the smallest arteries). 
For a suction pressure of -4kPa, the following figure 
shows how the time needed for clot removal increases as the 
diameter of the artery decreases. However in the case of one 
artery, the time taken for clot removal increases even when 
the clot length increases also. 
 
Figure 7.  Diameter artery vs time required to clot removal.  
This figure correlates with previous analysis completed 
for the  Middle Cerebral Artery (MCA) which was also 
consistent with  experimentally obtained data. In the case of 
the MCA artery, the diameter chosen for the ‘GP’ device and 
the catheter was 1 mm. The corresponding times for clot 
extraction for a 5cm clot ? 2 minutes to using a suction 
pressure of 40kPa. 
These results indicate the importance of carrying out clot 
extraction as quickly as possible, and indicate the potential 
uses and importance of such modelling. 
VII. CONCLUSIONS 
The development of this simulation model enables us to 
obtain an estimate of the minimum pressure required to 
perform the extraction of blood clots of different sizes and at 
different locations in the arteries of the Circle of Willis. In all 
cases we have taken the same age for the clot residing in the 
artery and the same values for the force of adhesion. This 
modelling has shown that the suction pressure together with 
the time required to complete clot removal are reasonable, 
and should be within acceptable clinical boundaries for any 
eventual potential use of the ‘GP’ TAD device in patients. 
Our results are similar to in-vitro experimentally obtained 
data. A similar analysis [7, 9] undertaken for its use in the 
MCA or the Popliteal artery enables further comparisons to 
be made. We compare the results of simulation modelling to 
measurements made in laboratory plastic tube models of 
arteries of comparable diameter where the ‘GP’ TAD was 
applied to successfully extract abattoir porcine blood clots. 
The suction pressures required for such clot extraction in 
these plastic tube models compare favourably with those 
predicted by the simulation modeling. We conclude therefore 
that the mathematical modelling presented may potentially 
be useful in predicting the performance of the GPTAD and 
could possibly be used in optimising the design of the 
device. 
Our modelling indicates that blood clots in arteries in the 
Circle of Willis presented could potentially be extracted. Our 
modelling can be used to predict the suction pressures and 
times taken for clot removal. A clot of length typically 5cm, 
causing 70% occlusion of the artery (where 30% of the 
occlusion is due to plaque in the artery) requires suction 
pressures of around 6kPa, to remove the clot and the time 
taken for clot extraction would typically take 30seconds. 
VIII. FUTURE WORKS 
The presented mathematical modelling is now being 
implemented to model and simulate different adhesion forces 
and a range of percentage arterial occlusions. In this future 
modeling include the systolic/diastolic pressure effects for 
case of arterial occlusion below 100% (including clot and 
plaque). 
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